• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清脑钠肽、高敏C反应蛋白、前胶原用于评估心肌梗死后植入式心律转复除颤器(ICD)患者室性心动过速的风险。

Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction.

作者信息

Blangy Hugues, Sadoul Nicolas, Dousset Brigitte, Radauceanu Anca, Fay Renaud, Aliot Etienne, Zannad Faiez

机构信息

Département de Cardiologie, CHU de Nancy, Hôpital de Brabois, Rue du Morvan, 54511, Vandoeuvre-lès-Nancy, France.

出版信息

Europace. 2007 Sep;9(9):724-9. doi: 10.1093/europace/eum102. Epub 2007 May 24.

DOI:10.1093/europace/eum102
PMID:17526509
Abstract

AIMS

Ventricular arrhythmia is the main cause of sudden cardiac death. Intracardiac strain, myocardial and extracellular matrix remodelling, and subsequent myocardial fibrosis are involved in arrhythmia pathogenesis. The present study investigates the relationship between cardiac fibrosis [procollagen type I aminoterminal peptide (PINP), procollagen type III aminoterminal peptide (PIIINP), TIMP1, membrane metalloproteinase I], pressure overload [brain natriuretic peptide (BNP)] inflammation [high sensitivity (hs)-C-reactive protein] serum markers, and the incidence of ventricular tachycardia (VT) in implantable cardioverter-defibrillators (ICD) recipients.

METHODS AND RESULTS

Serum markers were collected in 121 patients implanted for spontaneous sustained VT and a prior history of myocardial infarction. VT incidence was obtained during ICD interrogation. Over a 1 year period, 38 patients (31%) experienced at least 1 VT. In a multivariate analysis, a left ventricular ejection fraction <0.35 (OR = 2.19, 95%CI 1.00-4.79, P = 0.049), an increased serum BNP (OR = 3.75, 95%CI 1.46-9.67, P = 0.014), an increased hs-C-reactive protein (OR = 3.2, 95%CI 1.26-8.10, P = 0.006), an increased PINP (OR = 3.71, 95%CI 1.40-9.88, P = 0.009), and a decreased PIIINP (OR = 0.21, 95%CI 0.08-0.59, P = 0.003) were associated with a higher VT incidence.

CONCLUSION

In coronary artery disease patients: (1) BNP is not only a marker of left ventricular dysfunction, but also a marker of VT; (2) combined 'high PINP and low PIIINP' is a strong VT marker; and 3) inflammatory process is involved in VT pathogenesis.

摘要

目的

室性心律失常是心源性猝死的主要原因。心腔内应变、心肌及细胞外基质重塑以及随后的心肌纤维化参与心律失常的发病机制。本研究调查心脏纤维化[I型前胶原氨基端肽(PINP)、III型前胶原氨基端肽(PIIINP)、金属蛋白酶组织抑制因子1(TIMP1)、膜型金属蛋白酶1(MMP1)]、压力超负荷[脑钠肽(BNP)]、炎症[高敏(hs)-C反应蛋白]血清标志物与植入式心脏复律除颤器(ICD)植入者室性心动过速(VT)发生率之间的关系。

方法与结果

收集121例因自发性持续性VT植入且有心肌梗死病史患者的血清标志物。通过ICD问询获得VT发生率。在1年期间,38例患者(31%)发生至少1次VT。多因素分析显示,左心室射血分数<0.35(比值比[OR]=2.19,95%可信区间[CI]1.00-4.79,P=0.049)、血清BNP升高(OR=3.75,95%CI1.46-9.67,P=0.014)、hs-C反应蛋白升高(OR=3.2,95%CI1.26-8.10,P=0.006)、PINP升高(OR=3.71,95%CI1.40-9.88,P=0.009)以及PIIINP降低(OR=0.21,95%CI0.08-0.59,P=0.003)与较高的VT发生率相关。

结论

在冠心病患者中:(1)BNP不仅是左心室功能障碍的标志物,也是VT的标志物;(2)“高PINP和低PIIINP”组合是强有力的VT标志物;(3)炎症过程参与VT发病机制。

相似文献

1
Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction.血清脑钠肽、高敏C反应蛋白、前胶原用于评估心肌梗死后植入式心律转复除颤器(ICD)患者室性心动过速的风险。
Europace. 2007 Sep;9(9):724-9. doi: 10.1093/europace/eum102. Epub 2007 May 24.
2
Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm.促炎标志物和N末端脑钠肽原在植入式心律转复除颤器患者及电风暴中的作用
Cytokine. 2009 Sep;47(3):166-72. doi: 10.1016/j.cyto.2009.06.003. Epub 2009 Jul 14.
3
Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.心肌梗死后C反应蛋白在植入心脏复律除颤器患者中的预后作用:心肌梗死后C反应蛋白评估以指导除颤器植入(CAMI GUIDE)研究的设计
J Cardiovasc Med (Hagerstown). 2007 Apr;8(4):293-9. doi: 10.2459/01.JCM.0000263496.52656.95.
4
Comparison of N-terminal pro-brain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction.N 端前脑钠肽与电生理研究在预测心肌梗死后植入式心律转复除颤器患者未来结局中的比较。
Am J Cardiol. 2007 Aug 15;100(4):635-9. doi: 10.1016/j.amjcard.2007.03.074. Epub 2007 Jun 26.
5
Serum markers of deranged myocardial collagen turnover: their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure.血清心肌胶原代谢标志物紊乱:与心力衰竭患者心脏再同步除颤器治疗后恶性室性心律失常的关系。
Am Heart J. 2012 Oct;164(4):530-7. doi: 10.1016/j.ahj.2012.07.006.
6
Prognostic role of high-sensitivity C-reactive protein and B-type natriuretic peptide in implantable cardioverter-defibrillator patients.高敏C反应蛋白和B型利钠肽在植入式心脏复律除颤器患者中的预后作用
Pacing Clin Electrophysiol. 2012 Mar;35(3):275-82. doi: 10.1111/j.1540-8159.2011.03289.x. Epub 2011 Dec 8.
7
Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.致心律失常性右心室发育不良/心肌病中的室性心动过速:临床表现、危险分层及长期随访结果
Int J Cardiol. 2006 Mar 8;107(3):360-8. doi: 10.1016/j.ijcard.2005.03.049.
8
Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.植入式心律转复除颤器(ICD)患者室性心动过速/心室颤动(VT/VF)发生的预测因素:PROFIT研究结果
Europace. 2006 Aug;8(8):618-24. doi: 10.1093/europace/eul082.
9
Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies.植入前B型利钠肽浓度是未来合适的植入式心脏除颤器治疗的独立预测指标。
Heart. 2006 Feb;92(2):190-5. doi: 10.1136/hrt.2004.058198. Epub 2005 May 27.
10
[Brain natriuretic peptide (BNP) level predicts long term ventricular arrhythmias in patients with moderate to severe left ventricular dysfunction].
Harefuah. 2012 Jan;151(1):20-3, 63, 62.

引用本文的文献

1
Predictive value of inflammatory prognostic index for contrast-induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention.炎症性预后指数对行冠状动脉造影和/或经皮冠状动脉介入治疗的患者对比剂肾病的预测价值。
Sci Rep. 2024 Jul 9;14(1):15861. doi: 10.1038/s41598-024-66880-7.
2
Linking IL-6 and hsCRP among Indian patients with myocardial infarction.印度心肌梗死患者中白细胞介素-6与超敏C反应蛋白的关联
Bioinformation. 2024 Apr 30;20(4):378-385. doi: 10.6026/973206300200378. eCollection 2024.
3
Poor Nutritional Status Is Associated with Arrhythmic Events on 24-Hour Holter Recording.
营养状况差与 24 小时动态心电图记录的心律失常事件相关。
Med Princ Pract. 2022;31(4):368-375. doi: 10.1159/000524396. Epub 2022 Apr 8.
4
Complement C1q/Tumor Necrosis Factor-Related Protein-3 (CTRP3) is Significantly Decreased in Patients with Heart Failure and Closely Related with Ventricular Tachycardia.补体C1q/肿瘤坏死因子相关蛋白3(CTRP3)在心力衰竭患者中显著降低,且与室性心动过速密切相关。
Acta Cardiol Sin. 2021 May;37(3):278-285. doi: 10.6515/ACS.202105_37(3).20201019B.
5
Classic and Novel Biomarkers as Potential Predictors of Ventricular Arrhythmias and Sudden Cardiac Death.经典和新型生物标志物作为室性心律失常和心源性猝死的潜在预测指标
J Clin Med. 2020 Feb 20;9(2):578. doi: 10.3390/jcm9020578.
6
Prediction of sudden death in elderly patients with heart failure.老年心力衰竭患者猝死的预测
J Geriatr Cardiol. 2018 Feb;15(2):185-192. doi: 10.11909/j.issn.1671-5411.2018.02.008.
7
Higher High-Sensitivity C Reactive Protein is Associated with Future Premature Ventricular Contraction: a Community Based Prospective Cohort Study.高敏 C 反应蛋白与未来发生室性期前收缩相关:一项基于社区的前瞻性队列研究。
Sci Rep. 2018 Mar 26;8(1):5152. doi: 10.1038/s41598-018-22868-8.
8
Ventricular Tacyhcardia in A Patient with A Previous History of Endocarditis and Ankylosan Spondylitis: A Challenging Case.一名有感染性心内膜炎和强直性脊柱炎病史患者的室性心动过速:一个具有挑战性的病例
Eurasian J Med. 2016 Oct;48(3):222-224. doi: 10.5152/eurasianjmed.2016.0277.
9
Relationship of long-term prognosis to MMP and TIMP polymorphisms in patients after ST elevation myocardial infarction.ST段抬高型心肌梗死后患者长期预后与基质金属蛋白酶(MMP)和基质金属蛋白酶组织抑制因子(TIMP)基因多态性的关系。
J Appl Genet. 2017 Aug;58(3):331-341. doi: 10.1007/s13353-016-0388-8. Epub 2017 Jan 18.
10
Risk stratification for sudden cardiac death: current status and challenges for the future.心脏性猝死的风险分层:现状与未来挑战。
Eur Heart J. 2014 Jul 1;35(25):1642-51. doi: 10.1093/eurheartj/ehu176. Epub 2014 May 5.